DR. AGON
ActiveSummary
DR. AGON has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €89,868 and a net result of €83,868. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 64% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+40
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days acceptable
Liquidity short (current ratio 0.54 against 0.6 in 2024; short-term debt: 23.9% and cash: 4.9% of total assets), and 23.9% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
76.1%
Return on assets
71%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-05-2026, 71 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
71 d early
2024
24 d early
2023
8 d late
2022
32 d late
2021
25 d late
2020
1 d early
2019
7 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 5 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 August (4 of the last 5 filed years within 33 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€89,868▲ 31.3%
2024 · €68,448
Total assets
€118,133▼ 39.7%
2024 · €195,933
Net result
€83,868▲ 34.3%
2024 · €62,448
Working capital
-€12,912▲ 74.4%
2024 · -€50,416
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€108,912▲ 69.6%€93,713▼ 14.0%€83,910▼ 10.5%€79,051▼ 5.8%€106,397▲ 34.6%
Net result€86,104within the sector's middle half▲ 69.2%€74,677within the sector's middle half▼ 13.3%€66,730within the sector's middle half▼ 10.6%€62,448within the sector's middle half▼ 6.4%€83,868within the sector's middle half▲ 34.3%
Equity€141,109within the sector's middle half▲ 149%€215,786within the sector's middle half▲ 52.9%€163,203within the sector's middle half▼ 24.4%€68,448within the sector's middle half▼ 58.1%€89,868within the sector's middle half▲ 31.3%
Total assets€179,761within the sector's middle half▲ 110%€244,579within the sector's middle half▲ 36.1%€180,625within the sector's middle half▼ 26.1%€195,933within the sector's middle half▲ 8.5%€118,133below the sector's middle half▼ 39.7%
Debt€38,652▲ 33.0%€28,793▼ 25.5%€17,422▼ 39.5%€127,485▲ 632%€28,264▼ 77.8%
Working capital€134,975within the sector's middle half▲ 163%€212,474within the sector's middle half▲ 57.4%€91,364within the sector's middle half▼ 57.0%-€50,416below the sector's middle half-€12,912below the sector's middle half▲ 74.4%
Solvency78.5%within the sector's middle half▲ 12.4pp88.2%above the sector's middle half▲ 9.7pp90.4%above the sector's middle half▲ 2.1pp34.9%below the sector's middle half▼ 55.4pp76.1%within the sector's middle half▲ 41.1pp
Current ratio4.49within the sector's middle half▲ 1.628.38above the sector's middle half▲ 3.896.24within the sector's middle half▼ 2.140.60below the sector's middle half▼ 5.640.54below the sector's middle half▼ 0.06
Return on assets (ROA)47.9%above the sector's middle half▼ 11.5pp30.5%within the sector's middle half▼ 17.4pp36.9%above the sector's middle half▲ 6.4pp31.9%within the sector's middle half▼ 5.1pp71.0%above the sector's middle half▲ 39.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 35% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €118,133
Fixed assets
€102,781 ▼ 13.5%
Current assets
€15,352 ▼ 80.1%
Equity and liabilities €118,133
Equity
€89,868 ▲ 31.3%
Debt
€28,264 ▼ 77.8%
Debt's share of the balance-sheet total falls from 65.1% to 23.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€122,481▲
2024 · €97,827
Cash flow
€99,952▲
2024 · €81,224
Debt to equity
0.31▼
2024 · 1.86
ROE
93.3%▲
2024 · 91.2%
Interest coverage
379.67▼
2024 · 407.26
Debt ≤ 1 year
€28,264▼
2024 · €127,485
Income taxes
€22,206▲
2024 · €16,363
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,377 | €4,058 | €10,691 | €18,776 | €16,083 | ▼ 14.3% |
| Other operating charges640/8 | €111 | €460 | €499 | €513 | €528 | ▲ 2.8% |
| Gross operating margin9900 | €111,400 | €98,231 | €95,101 | €98,340 | €123,008 | ▲ 25.1% |
| Operating profit (loss)9901 | €108,912 | €93,713 | €83,910 | €79,051 | €106,397 | ▲ 34.6% |
| Financial income75/76B | - | - | €17 | - | - | - |
| Recurring financial income75 | - | - | €17 | - | - | - |
| Financial charges65/66B | €529 | €173 | €121 | €240 | €323 | ▲ 34.3% |
| Recurring financial charges65 | €529 | €173 | €121 | €240 | €323 | ▲ 34.3% |
| Profit (loss) for the period before taxes9903 | €108,383 | €93,540 | €83,806 | €78,811 | €106,075 | ▲ 34.6% |
| Income taxes67/77 | €22,280 | €18,863 | €17,076 | €16,363 | €22,206 | ▲ 35.7% |
| Profit (loss) for the period9904 | €86,104 | €74,677 | €66,730 | €62,448 | €83,868 | ▲ 34.3% |
| Profit (loss) for the period to be appropriated9905 | €86,104 | €74,677 | €66,730 | €62,448 | €83,868 | ▲ 34.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €179,761 | €244,579 | €180,625 | €195,933 | €118,133 | ▼ 39.7% |
| Fixed assets21/28 | €6,134 | €3,312 | €71,839 | €118,864 | €102,781 | ▼ 13.5% |
| Tangible fixed assets22/27 | €6,134 | €3,312 | €71,839 | €55,008 | €38,925 | ▼ 29.2% |
| Plant, machinery and equipment23 | €2,550 | €736 | €2,319 | €1,546 | €1,073 | ▼ 30.6% |
| Furniture and vehicles24 | €3,584 | €2,576 | €69,520 | €53,462 | €37,852 | ▼ 29.2% |
| Financial fixed assets28 | - | - | - | €63,856 | €63,856 | = |
| Current assets29/58 | €173,627 | €241,267 | €108,786 | €77,068 | €15,352 | ▼ 80.1% |
| Amounts receivable within one year40/41 | - | €3,375 | €2,924 | €3,637 | €3,637 | = |
| Trade receivables40 | - | €2,239 | - | - | - | - |
| Other amounts receivable41 | - | €1,137 | €2,924 | €3,637 | €3,637 | = |
| Cash at bank and in hand54/58 | €169,714 | €236,236 | €103,085 | €67,268 | €5,769 | ▼ 91.4% |
| Deferred charges and accrued income490/1 | €3,913 | €1,655 | €2,778 | €6,163 | €5,945 | ▼ 3.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €179,761 | €244,579 | €180,625 | €195,933 | €118,133 | ▼ 39.7% |
| Equity10/15 | €141,109 | €215,786 | €163,203 | €68,448 | €89,868 | ▲ 31.3% |
| Contributions10/11 | €6,000 | €6,000 | €6,000 | €6,000 | €6,000 | = |
| Reserves13 | €135,109 | €209,786 | €157,203 | €62,448 | €83,868 | ▲ 34.3% |
| Distributable reserves133 | €135,109 | €209,786 | €157,203 | €62,448 | €83,868 | ▲ 34.3% |
| Amounts payable17/49 | €38,652 | €28,793 | €17,422 | €127,485 | €28,264 | ▼ 77.8% |
| Amounts payable within one year42/48 | €38,652 | €28,793 | €17,422 | €127,485 | €28,264 | ▼ 77.8% |
| Trade debts44 | €5,378 | €13,212 | €1,756 | €10,675 | €2,913 | ▼ 72.7% |
| Suppliers440/4 | €5,378 | €13,212 | €1,756 | €10,675 | €2,913 | ▼ 72.7% |
| Taxes, remuneration and social security45 | €18,014 | €6,000 | €2,700 | €2,400 | €4,460 | ▲ 85.8% |
| Taxes450/3 | €18,014 | €6,000 | €2,700 | €2,400 | €4,460 | ▲ 85.8% |
| Other amounts payable47/48 | €15,259 | €9,581 | €12,966 | €114,409 | €20,892 | ▼ 81.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €86,104 | €74,677 | €66,730 | €62,448 | €83,868 | ▲ 34.3% |
| + Depreciation and write-downs630 | €2,377 | €4,058 | €10,691 | €18,776 | €16,083 | ▼ 14.3% |
| Operating cash flow (approximation) | €88,481 | €78,735 | €77,421 | €81,224 | €99,952 | ▲ 23.1% |
| Investment in fixed assets (approximation) | - | -€1,237 | -€79,218 | -€65,801 | €0 | ▲ 100% |
| Change in cash | - | €66,522 | -€133,152 | -€35,817 | -€61,499 | ▼ 71.7% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
07-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
08-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 8 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
31-12
Financial
Equity above €200,000Eq €215,786 ▲52.9%
4 profitable years in a row build equity to €215,786.
25-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 25 days late
2021
31-12
Financial
Highest result since 2019net €86,104 ▲69.2%
Operating result €108,912, net result €86,104, both a record.
31-12
Financial
Equity above €100,000Eq €141,109 ▲149%
3 profitable years in a row build equity to €141,109.
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
24-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2019
Ground area
1,993 m²
Building footprint
486 m²
Volume, LiDAR
2,329 m³
2 parcels, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
DR. AGON
since 20192.293.882.625
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31036G0296/00Y000 | Flanders | 1,413 m² | 1 · 374 m² | 10.6 m · 1 fl. |
| 31512B0509/00E000 | Flanders | 580 m² | 1 · 112 m² | 8.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
20%
According to the 2025 annual accounts of DR. AGON and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
DOCTEUR MARIE HONHON
BE 0768.846.051
Blégny · Eq €89,919
DR. CHARLOTTE DEBUNNE
BE 0824.471.492
Wevelgem · Eq €89,934
ExpMED RZ
BE 0717.836.721
Liège · Eq €89,761
Dr. Clara Mertens
BE 0798.951.980
Kalmthout · Eq €90,038
Docteur Eric SALMON
BE 1000.605.973
Trooz · Eq €89,681
Of 9,130 companies in sector 86210 we hold annual accounts for 6,337. 5,190 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded09-09-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0733841028
Also
9925:BE0733841028
Registered
30-10-2023
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.